AzTrials
AzTrials

Sarcopenia in ElderlyNCT07269600

Effects of Sarcopenia on Proprioception, Kinesiophobia, and Pressure Pain Threshold

An observational study of Sarcopenia in Elderly, run by Atılım University at 1 site in Turkey (Türkiye).

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The aim of this observational study is to reveal the effect of sarcopenia on cervical proprioception, kinesiophobia and pressure pain threshold in geriatric individuals living in a nursing home. Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
Conditions the study is for
Sarcopenia in Elderly
How many people
31 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Apr 2025to 30 Jan 2026
How long will I take part?
2 Months
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Geriatric people who lives in a nursing home in Ankara called Nevia Oran nursing home

Who may be able to join

  • Being 65 years of age or older
  • Receiving a score of 24 or higher, which is considered mentally healthy, according to the mini mental assessment
  • Having at least 91 points or more according to the Barthel daily living activities index (being mildly dependent or completely independent)

Who cannot join

  • Having a disability (such as limb, vision, hearing loss),
  • Having a serious neurological, orthopedic or rheumatological disorder that may affect proprioception,
  • Having uncontrolled hypertension/diabetes,
  • Having pain in the spine and/or extremities,
  • Having a psychiatric disease diagnosis.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Nevia Oran Nursing Home

    Ankara, çankaya, 06530

Other trials in Turkey (Türkiye)

About this study

Official title: The Effects of Sarcopenia on Cervical Proprioception, Kinesiophobia and Pressure Pain Threshold in Geriatric Nursing Home Residents

The aim of this observational study is to reveal the effect of sarcopenia on cervical proprioception, kinesiophobia and pressure pain threshold in geriatric individuals living in a nursing home. The main questions it aims to answer are as follows:

The presence of sarcopenia in geriatric individuals living in a nursing home is effective/not effective on cervical proprioception.

Read more

The presence of sarcopenia in geriatric individuals living in a nursing home is effective/not effective on kinesiophobia.

The presence of sarcopenia in geriatric individuals living in a nursing home is effective/not effective on pressure pain threshold.

As a result of the evaluations, we will obtain the answers to the above questions with the surveys and measurements conducted with the participants divided into two groups as control and sarcopenia groups.

Read the detailed description

Aging, which is a physiological process, is a period that reduces or limits the activity level and functionality of individuals, making them socially, physically and emotionally dependent to different degrees. With increasing age, changes may occur in physiological, psychological, cognitive and social areas, while the individual's cognitive and functional capacity decreases, an increase in the incidence of chronic diseases is observed. In light of today's scientific, medical, technological and economic developments, the population of both our country and the world is increasing. The 'geriatric syndrome concept' that we encounter due to the increasing elderly population has brought with it a series of sub-concepts. The most important of these concepts is the concept of sarcopenia, which has been the subject of many studies in recent years. Sarcopenia is defined as a progressive and widespread loss of muscle mass, function and strength. The EWGSOP, known as the European Working Group on Sarcopenia in the Elderly, defined sarcopenia in 2010 as a syndrome characterized by progressive and widespread loss of skeletal muscle mass and function, associated with risks such as physical disability, poor quality of life and death.

Sarcopenia, which is the most common among geriatric syndromes, significantly affects the physical, social and psychological life of the individual, while visibly restricting daily life activities. The presence of sarcopenia increases the risk and duration of hospitalization due to the loss of strength, falls and fragility it brings, and significantly increases the cost of care. Determining the parameters affected by sarcopenia in the geriatric population is essential for the establishment of preventive treatment algorithms and providing clinicians with a comprehensive perspective on sarcopenia.

The first factor that the presence of sarcopenia can affect may be proprioception. It is thought that the impairments in proprioception may be due to a decrease in the dynamic response of muscle spindles and axonal atrophy leading to impaired processing of sensory information. The cervical region is especially critical in terms of proprioception. The suboccipital muscles in the cervical region contain a large number of mechanoreceptors for proprioception, and this region is defined as the main source of proprioceptive information. However, there is no study in the literature investigating the relationship between sarcopenia and cervical proprioception or the effect of sarcopenia on cervical proprioception.

Another issue that needs to be addressed in the presence of sarcopenia is kinesiophobia. In a study conducted in 2024, the relationship between sarcopenia risk and kinesiophobia in geriatric individuals was evaluated and it was observed that sarcopenia risk increased the risk of kinesiophobia.

Finally, another issue that we want to evaluate in the presence of sarcopenia is the pressure pain threshold. No study investigating the relationship between sarcopenia and pressure pain threshold was found in the literature.

In light of the above information, the aim of the current study is to reveal the effect of sarcopenia on cervical proprioception, kinesiophobia and pressure pain threshold in geriatric individuals living in a nursing home.

Purpose: To reveal the effect of sarcopenia on cervical proprioception, kinesiophobia and pressure pain threshold in geriatric individuals living in a nursing home.

The current study was planned as a prospective, controlled study at the Private Nevia Oran Nursing Home and Elderly Care Center.

Universe and sample of the study: The study will be conducted with the participation of individuals living in the Private Nevia Oran Nursing Home and Elderly Care Center located in the city center of Ankara.

Data collection: Data will be collected by the researcher using a face-to-face interview technique .

To determine the sarcopenia classification, hand grip strength will be measured with the Jamar hand dynamometer, and physical performance will be evaluated with the the 4 m walking test . Bioimpedance Analysis (BIA) and anthropometric measurement methods will be used to measure muscle mass. Based on the results obtained, individuals will be divided into 2 groups as those with sarcopenia and those without sarcopenia.

Those with no decrease in muscle mass, grip strength and muscle performance will form the asymptomatic control group, while those with decreased muscle mass, grip strength and/or performance will be included in the sarcopenic group (experimental group).

Joint position error test will be used to assess cervical proprioception. An algometer will be used to assess the pressure pain threshold. The kinesiophobia causes scale and pain catastrophizing scale will be used to assess fear of movement and pain catastrophizing.

Keywords
Pressure pain threshold, sarcopenia, crevical proprioception, kinesiophobia
Medical subject headings
Sarcopenia, Kinesiophobia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT07269600
Study groupRoleWhat they receive
control groupindividuals without sarcopenia
sarcopenic groupindividuals with sarcopenia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of cervical proprioception

    Cervical proprioception was assessed using joint position error test . While seated, the participant faced a board positioned 90 cm away at head level, consisting of concentric circles (40 cm diameter, 1-cm increments), and wore a cap with a mounted laser pointer The participant first aligned the laser with the central point to establish the neutral position, then-with eyes open-was guided through flexion, extension, right/left rotation, and right/left lateral flexion, returning to neutral after each movement. The same six movements were then actively performed with eyes closed . Six repetitions were completed for each direction, and the point at which the laser stopped was marked on the board after every trial . The mean of these points was calculated, and angular deviation from the target was determined using the arctan method based on the fixed distance to the board. A deviation of more than 4 degrees was considered to indicate impaired proprioception.

    Measured: 0-8 months

  2. Assessment of kinesiophobia

    Kinesiophobia was assessed using the Kinesiophobia Causes Scale (KCS) . Developed by Kocjan and Knapik, the scale identifies the biological and psychological sources of fear of movement and contributes to understanding the underlying causes of reduced motor activity. It comprises two domains: biological and psychological. The biological domain includes morphological factors, movement requirements, energy resources, biological drives, negative experiences, motor competence, and beliefs related to body care, while the psychological domain assesses factors such as confidence, self-efficacy, and social interaction that contribute to avoidance behavior . The Turkish validity and reliability study was conducted by Çayır et al. The greater this value in the range of 0-5, the more valid the person's level of kinesiophobia.

    Measured: 0-8 months

  3. Assessment of pressure pain threshold

    A pressure algometer (Baseline Force Gauge Model 12-0304; Baseline, NY, USA) will be used to assess the pressure pain threshold. The patient will be seated, and pressure will be applied perpendicularly and bilaterally using the algometer to different points in the cervical region (2 cm lateral to the C2 and C7spinous processes, at the midpoint of the upper part of the trapezius muscle) at a rate of approximately 3 N/s over an area of 0.5 cm² . The participant will be asked to report the moment they first felt discomfort and the pressure value at this moment will be recorded as the "pressure pain threshold". A second measurement will be taken at each region after an interval, the average of the two measurements will be noted.

    Measured: 0-8months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2025
  2. Study start1 Apr 2025
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion30 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
31 participants (actual)
Target duration
2 Months
IDs, dates and publications
ClinicalTrials.gov ID
NCT07269600
Sponsor's protocol ID
Beyza-ftr-01
Status last verified
Mar 2025
First submitted
14 Nov 2024
Last updated
15 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: only IPD used in the results

Publications

  • Coşkun-Çelik, E., Medulla spinalis yaralanmalı hastalardaki nöropatik ağrıya akupunktur benzeri TENS'in etkisi. Uzmanlık Tezi, 2005.

  • Gürel, Ö., Değişik muskuloskeletal sistem hastalıklarının basınç ağrı eşiği üzerine etkisi. Uzmanlık Tezi, Haydarpaşa Numune Eğitim ve Araştırma Hastanesi Fiziksel Tıp ve Rehabilitasyon Kliniği, İstanbul, 2009.

  • Mekanizmaları, E.S.A., Ağrı Sendromları ve Tedavisi 2. baskı. İstanbul: Gizben Matbaacılık, 2003: p. 33-42.261.

  • Düzel, V., Hemşire ve hastaların postoperatif ağrı değerlendirmelerinin karşılaştırılması. Çukurova Üniversitesi Sağlık Bilimleri Enstitüsü Yüksek Lisans Tezi. Adana, 2008.

  • Akyol, B., Üst ekstremite ve bel ağrı tanısı konulmuş sedanter kadınlarda kalistenik egzersizlerin ağrı eşiği üzerine etkisi. Yayımlanmamış doktora tezi), İnönü Üniversitesi, Malatya, 2014.

  • Wheeler CHB, Williams ACC, Morley SJ. Meta-analysis of the psychometric properties of the Pain Catastrophizing Scale and associations with participant characteristics. Pain. 2019 Sep;160(9):1946-1953. doi: 10.1097/j.pain.0000000000001494.

    PubMed 30694929
  • Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O'Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med. 1997 Dec;20(6):589-605. doi: 10.1023/a:1025570508954.

    PubMed 9429990
  • Ugurlu, M., et al., Validity of Turkish form of Pain Catastrophizing Scale and modeling of the relationship between pain-related disability with pain intensity, cognitive, and emotional factors. Psychiatry and Clinical Psychopharmacology, 2017. 27(2): p. 189-196.

  • Sullivan, M.J., S.R. Bishop, and J. Pivik, The pain catastrophizing scale: development and validation. Psychological assessment, 1995. 7(4): p. 524.,

  • Kocjan, J. and A. Knapik, Barriers of physical activity (kinesiophobia) in patients subjected to cardiac rehabilitation. Baltic journal of health and physical activity, 2014. 6(4): p. 7.

  • Knapik A, Saulicz E, Gnat R. Kinesiophobia - introducing a new diagnostic tool. J Hum Kinet. 2011 Jun;28:25-31. doi: 10.2478/v10078-011-0019-8. Epub 2011 Jul 4.

    PubMed 23487514
  • Çayır, M., N.A. Durutürk, and M.A. Tekindal, Kinezyofobi Nedenleri Ölçeği'nin Türkçe uyarlamasının geçerlik ve güvenirliği. Journal of Exercise Therapy and Rehabilitation, 2020. 7(1): p. 64-73.

  • GENÇ, F.Z. and N. BİLGİLİ, Huzurevinde Yaşayan Yaşlılarda Kinezyofobi ve İlişkili Faktörlerin Değerlendirilmesi. Balıkesir Sağlık Bilimleri Dergisi, 2023. 12(2): p. 294-303.

  • Benjaminse A, Sell TC, Abt JP, House AJ, Lephart SM. Reliability and precision of hip proprioception methods in healthy individuals. Clin J Sport Med. 2009 Nov;19(6):457-63. doi: 10.1097/JSM.0b013e3181bcb155.

    PubMed 19898072
  • Ager AL, Borms D, Deschepper L, Dhooghe R, Dijkhuis J, Roy JS, Cools A. Proprioception: How is it affected by shoulder pain? A systematic review. J Hand Ther. 2020 Oct-Dec;33(4):507-516. doi: 10.1016/j.jht.2019.06.002. Epub 2019 Aug 31.

    PubMed 31481340

Questions about this trial

What is this clinical trial studying?

An observational study of Sarcopenia in Elderly, run by Atılım University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 15 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of cervical proprioception (time frame: 0-8 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07269600, which also lists 45 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Dec 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in